Use of High-dose Intravenous Immunoglobulin as Initial Therapy for Heparin-induced Thrombocytopenia in Patients With High Bleeding Risk.
Saved in:
| Title: | Use of High-dose Intravenous Immunoglobulin as Initial Therapy for Heparin-induced Thrombocytopenia in Patients With High Bleeding Risk. |
|---|---|
| Authors: | Grazioli AV; Department of Medicine, Program in Trauma, R. Adams Cowley Shock Trauma Center, University of Maryland School of Medicine, Baltimore, MD. Electronic address: agrazioli@som.umaryland.edu., Plazak ME; Department of Pharmacy, University of Maryland Medical Center, Baltimore, MD., Shen CS; Department of Emergency Medicine, Program in Trauma, R. Adams Cowley Shock Trauma Center, University of Maryland School of Medicine, Baltimore, MD., Scalea TM; Department of Surgery, Program in Trauma, R. Adams Cowley Shock Trauma Center, University of Maryland School of Medicine, Baltimore, MD., Kundi R; Department of Surgery, Program in Trauma, R. Adams Cowley Shock Trauma Center, University of Maryland School of Medicine, Baltimore, MD., Riojas RA; Department of Surgery, University of Maryland School of Medicine, Baltimore, MD., Belyayev LA; Department of Surgery, University of Maryland School of Medicine, Baltimore, MD. |
| Source: | Journal of cardiothoracic and vascular anesthesia [J Cardiothorac Vasc Anesth] 2026 Feb; Vol. 40 (2), pp. 660-664. Date of Electronic Publication: 2025 Aug 23. |
| Publication Type: | Case Reports; Journal Article |
| Journal Info: | Publisher: W.B. Saunders Country of Publication: United States NLM ID: 9110208 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-8422 (Electronic) Linking ISSN: 10530770 NLM ISO Abbreviation: J Cardiothorac Vasc Anesth Subsets: MEDLINE; In Process |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
